Indian API space attracts M&A deals
Fuelled by an ‘Atmanirbhar’ push and growing preference for India-made pharmaceutical raw materials over Chinese, the Active Pharmaceutical Ingredient (API) sector is in the spotlight...
Continue ReadingBiogen trial of ALS drug fails main goal, but company says data are encouraging
A late-stage trial of Biogen Inc’s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary...
Continue ReadingIntas launches the World’s first SB-100mg Itraconazole
One of the world’s leading pharmaceutical companies, Intas Pharmaceuticals, has made a progressive breakthrough in the Antifungal Therapy domain with the launch of the world’s...
Continue ReadingTime for Indian Pharma to Digest “RICE”?
Years ago, David Ogilvy said,“You aren’t advertising to a standing army; you are advertising to a moving parade.” This parade has turned into a crowd...
Continue ReadingBiological E seeks DGCI nod for phase-3 trial of Corbevax as booster dose
The company has sought the approval of the DGCI to conduct the phase-three clinical study of Corbevax as a single booster dose in those fully...
Continue ReadingEverything You Need to Know About Merck’s Game-Changing Covid Pill
Molnupiravir, an antiviral pill being developed by Merck & Co., has been touted as a potential game changer in the fight against Covid-19. The experimental...
Continue ReadingBharat Biotech to produce world’s 1st malaria vaccine approved by WHO
Bharat Biotech will produce the world’s first malaria vaccine approved by the World Health Organization, as part of global efforts to battle the deadly fever....
Continue ReadingSun Pharma launches cough syrup Chericof 12 in India
Sun Pharmaceutical Industries Ltd. on Tuesday, September 28, 2021, announced the launch of a novel formulation in cough management – Chericof 12 (Dextromethorphan Hydrobromide 30...
Continue ReadingScientists’ body expresses concern over WHO not granting EUL for Covaxin
A national network of scientists, AIPSN, has expressed concern over the World Health Organisation not granting emergency use listing for ICMR-Bharat Biotech’s Covaxin. The All...
Continue Reading